US Patent 11939343 Sting agonist compounds and methods of use

Is a

Patent

Patent attributes

Patent Applicant

Mersana Therapeutics

Current Assignee

Mersana Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

119393430

Patent Inventor Names

Soumya S. Ray0

Jeremy R. Duvall0

Eugene W. Kelleher0

Joshua D. Thomas0

Brian D. Jones0

Keith W. Bentley0

Dorin Toader0

Date of Patent

March 26, 2024

Patent Application Number

174699830

Date Filed

September 9, 2021

Patent Citations

‌

US Patent 8603474 Membrane transporter NaPi2b (SCL34A1) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy

‌

US Patent 11596694 Compositions and methods for predicting response to NaPi2b-targeted therapy

‌

US Patent 10189820 Heterocyclic amides useful as protein modulators

‌

US Patent 7488802 Antibodies against PD-1

‌

US Patent 7521051 Methods of upmodulating adaptive immune response using anti-PD-1 antibodies

‌

US Patent 8008449 Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics

‌

US Patent 8168757 PD-1 binding proteins

‌

US Patent 8354509 Antibodies to human programmed death receptor PD-1

Patent Primary Examiner

CPC Code

...

Patent abstract

The present disclosure relates to STING (Stimulator of Interferon Genes) agonist compounds, methods of making the compounds and their methods of use.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 11939343 Sting agonist compounds and methods of use

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 11939343 Sting agonist compounds and methods of use